Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1610177 | 0.67 | DRD4 (0.35) | DRD4DRD2 | |
| SCHEMBL12489993 | 0.67 | MAOA (0.45) | DRD4DRD2 | |
| SCHEMBL21484092 | 0.65 | CYP2A6 (0.36) | DRD4DRD2 | |
| SCHEMBL6421992 | 0.65 | HTR2C (0.45) | DRD4 | |
| SCHEMBL15014621 | 0.64 | HPGD (0.47) | — | |
| Hydrochloric Acid SCHEMBL31119454 | 0.64 | HTR2C (0.44) | DRD4 | |
| Hydrochloric Acid SCHEMBL28877979 | 0.64 | HTR2C (0.44) | DRD4 | |
| SCHEMBL14861328 | 0.63 | PDK2 (0.45) | — | |
| SCHEMBL4429320 | 0.63 | PLAU (0.40) | DRD2 | |
| SCHEMBL29341580 | 0.63 | PDK2 (0.33) | DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086759-A1 | CHEMICAL COMPOUNDS | SYNGENTA CROP PROTECTION, INC. (US) | 2011-04-14 | — | — | US | disclosed |
| EP-2237669-A2 | CHEMICAL COMPOUNDS | Syngenta Limited (GB) | 2010-10-13 | — | — | EP | disclosed |
| WO-2009081112-A2 | CHEMICAL COMPOUNDS | SYNGENTA LIMITED (GB) | 2009-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086759-A1 | CHEMICAL COMPOUNDS | DDT, PNPO, CBR3 | DRD4 1217/4885DRD2 1861/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.